Solaris Endovascular announced 12-month results from the Solaris SX iliac postmarket clinical follow-up study of the company&rs ...

Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeG ...

Angiolutions announced that the first patient has been treated in a first-in-human (FIH) study evaluating the safety and ...

Rampart IC, a developer of radiation shielding for interventional suites, announced new data on the reduction in radiation ...

Penumbra Inc. announced it has secured CE Mark approval for its Lightning Bolt 12 and Lightning Bolt 6X with Trax. These next-g ...

In a pair of randomized, observer-blinded clinical trials designed to evaluate optimal management of asymptomatic carotid ...

Imperative Care, Inc. announced late-breaking, real-world data from a multicenter review of 124 consecutive ischemic stroke ...

Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced it has secured a $53 million firs ...

Royal Philips announced the expanded commercial availability of its LumiGuide device guidance across Europe and the United Stat ...

Healionics Corporation, a developer of synthetic biomaterial-based medical devices, announced recently that 24-month clinical ...

Okami Medical, Inc., a developer of vascular embolization solutions, announced that Drew Hykes was appointed President and ...

Humacyte, Inc. announced that multiple presentations on the company’s acellular tissue-engineered vessel (ATEV) were del ...